SEEDPG
GILD icon

S.E.E.D. Planning Group’s Gilead Sciences GILD Stock Holding History

S.E.E.D. Planning Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Hold
2,000
– – 0.08% 75
2025
Q4 		$245K Hold
2,000
– – 0.07% 77
2025
Q3 		$222K Buy
+2,000
New +$227K 0.06% 79

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

S.E.E.D. Planning Group's GILD Position: Q1 2026 in Review

S.E.E.D. Planning Group held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,000 shares worth $279K. The position accounts for 0.08% of the portfolio, ranked #75.

S.E.E.D. Planning Group first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • S.E.E.D. Planning Group held 2,000 shares of Gilead Sciences worth $279K as of Q1 2026.
  • S.E.E.D. Planning Group left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.08% of S.E.E.D. Planning Group's portfolio in Q1 2026, its #75 holding.
  • S.E.E.D. Planning Group first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on S.E.E.D. Planning Group's 13F filing for Q1 2026, filed 23 Apr 2026.